Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
32.46
-0.29 (-0.89%)
Mar 11, 2025, 4:00 PM EST - Market closed
Royalty Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 11, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 18,712 | 11,334 | 12,497 | 17,432 | 17,116 | 19,426 | Upgrade
|
| Market Cap Growth | -9.30% | -9.30% | -28.31% | 1.85% | -11.89% | - | Upgrade
|
| Enterprise Value | 25,337 | 21,332 | 21,132 | 27,333 | 26,687 | 28,409 | Upgrade
|
| Last Close Price | 32.46 | 25.34 | 27.06 | 37.12 | 36.75 | 45.42 | Upgrade
|
| PE Ratio | 16.98 | 13.19 | 11.01 | 407.00 | 27.62 | 39.23 | Upgrade
|
| Forward PE | 6.95 | 6.09 | 7.47 | 10.32 | 13.00 | 19.16 | Upgrade
|
| PS Ratio | 6.43 | 5.01 | 5.31 | 7.79 | 7.48 | 9.15 | Upgrade
|
| PB Ratio | 2.08 | 1.10 | 1.24 | 1.83 | 1.67 | 1.96 | Upgrade
|
| P/TBV Ratio | 1.63 | 1.63 | 1.92 | 3.11 | 2.97 | 4.06 | Upgrade
|
| P/FCF Ratio | 6.76 | 4.09 | 4.18 | 8.13 | 8.48 | 9.55 | Upgrade
|
| P/OCF Ratio | 6.76 | 4.09 | 4.18 | 8.13 | 8.48 | 9.55 | Upgrade
|
| PEG Ratio | 0.86 | 2.14 | 2.65 | 0.94 | 1.12 | 1.97 | Upgrade
|
| EV/Sales Ratio | 11.19 | 9.42 | 8.98 | 12.22 | 11.66 | 13.39 | Upgrade
|
| EV/EBITDA Ratio | - | - | 14.11 | 29.44 | 18.36 | 16.87 | Upgrade
|
| EV/EBIT Ratio | 19.60 | 16.50 | 14.16 | 29.62 | 18.65 | 17.11 | Upgrade
|
| EV/FCF Ratio | 9.15 | 7.70 | 7.07 | 12.75 | 13.23 | 13.96 | Upgrade
|
| Debt / Equity Ratio | 0.74 | 0.74 | 0.61 | 0.75 | 0.69 | 0.59 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 4.10 | 7.66 | 4.88 | 3.46 | Upgrade
|
| Debt / FCF Ratio | 2.75 | 2.75 | 2.05 | 3.32 | 3.52 | 2.86 | Upgrade
|
| Asset Turnover | 0.13 | 0.13 | 0.14 | 0.13 | 0.14 | 0.15 | Upgrade
|
| Quick Ratio | 1.43 | 1.43 | 7.78 | 2.11 | 16.77 | 8.73 | Upgrade
|
| Current Ratio | 1.44 | 1.44 | 7.90 | 2.19 | 16.81 | 8.76 | Upgrade
|
| Return on Equity (ROE) | 13.03% | 13.03% | 17.34% | 2.33% | 12.32% | 21.22% | Upgrade
|
| Return on Assets (ROA) | 4.67% | 4.67% | 5.62% | 3.36% | 5.33% | 7.29% | Upgrade
|
| Return on Capital (ROIC) | 4.73% | 4.73% | 5.68% | 3.39% | 5.41% | 7.38% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.62% | 7.62% | 9.20% | 5.90% | 8.25% | 10.57% | Upgrade
|
| Earnings Yield | 4.59% | 7.58% | 9.08% | 0.25% | 3.62% | 5.02% | Upgrade
|
| FCF Yield | 14.80% | 24.43% | 23.91% | 12.30% | 11.79% | 10.47% | Upgrade
|
| Dividend Yield | 2.71% | 3.31% | 2.96% | 2.05% | 1.85% | 0.66% | Upgrade
|
| Payout Ratio | 46.03% | 43.83% | 31.58% | 778.21% | 46.02% | 40.80% | Upgrade
|
| Buyback Yield / Dilution | 1.46% | 1.46% | -37.66% | -5.59% | -10.48% | - | Upgrade
|
| Total Shareholder Return | 4.17% | 4.77% | -34.70% | -3.54% | -8.63% | 0.66% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.